Enliven Therapeutics, Inc. (ELVN) - Latest Market Data

Price & Market Data

Price: $42.30

Daily Change: +$2.71 / 6.41%

Daily Range: $39.70 - $43.23

Market Cap: $2,576,279,040

Daily Volume: 1,136,845

Performance Metrics

1 Week: 1.73%

1 Month: -3.49%

3 Months: 51.45%

6 Months: 139.9%

1 Year: 122.5%

YTD: 174.7%

About Enliven Therapeutics, Inc. (ELVN)

Stay informed about Enliven Therapeutics, Inc. (ELVN)'s market activity. The stock is holding at 42.30, showing a daily change of +$2.71 / 6.41%. Its market capitalization reaches 2,576,279,040. Performance metrics include YTD (174.7%) and various other periods like 1-week and 6-month returns.

Company Details

Employees: 60

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.

Selected stocks

LightPath Technologies, Inc. (LPTH)

Wen Acquisition Corp (WENN)

ASE Technology Holding Co., Ltd. (ASX)

Ohmyhome Limited (OMH)

Stepan Company (SCL)